NuVasive, Inc. provided earnings guidance for the fourth quarter and the full year ended December 31, 2013. For the quarter, the company expects preliminary revenue of approximately $189 million, approximately 14% growth versus fourth quarter 2012.

The company anticipates full year 2013 revenue will approximate $683 million. The revenue results compare to previously issued guidance of approximately $670 million in revenue for the full year 2013. The company also anticipates that full year 2013 non-GAAP operating margin will exceed previously issued guidance of approximately 14.5%.

The company expects 2014 revenue to approximate $725 million, in line with the mid-single digit revenue growth guidance that the company communicated previously. Revenue guidance for 2014 contemplates continued market share gains within a stabilizing domestic spine market.